Deltec Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.42M Sell
9,000
-5,000
-36% -$789K 0.22% 63
2026
Q2
$2.22M Buy
14,000
+4,000
+40% +$541K 0.33% 53
2026
Q1
$1.28M Hold
10,000
– – 0.23% 63
2025
Q4
$1.22M Buy
+10,000
New +$1.15M 0.2% 73
2023
Q4
– Sell
-36,200
Closed -$2.64M – 171
2023
Q3
$2.64M Buy
36,200
+8,000
+28% +$639K 0.6% 43
2023
Q2
$2.35M Buy
+28,200
New +$2.36M 0.51% 50
2022
Q2
– Sell
-6,500
Closed -$584K – 261
2022
Q1
$584K Hold
6,500
– – 0.1% 137
2021
Q4
$728K Hold
6,500
– – 0.12% 131
2021
Q3
$817K Hold
6,500
– – 0.12% 126
2021
Q2
$880K Buy
6,500
+3,000
+86% +$394K 0.12% 136
2021
Q1
$475K Hold
3,500
– – 0.07% 210
2020
Q4
$493K Hold
3,500
– – 0.08% 169
2020
Q3
$390K Hold
3,500
– – 0.07% 165
2020
Q2
$392K Sell
3,500
-9,900
-74% -$975K 0.08% 145
2020
Q1
$1.04M Sell
13,400
-6,100
-31% -$540K 0.29% 61
2019
Q4
$1.86M Sell
19,500
-25,700
-57% -$2.22M 0.38% 54
2019
Q3
$3.45M Sell
45,200
-7,500
-14% -$623K 0.87% 32
2019
Q2
$4.62M Buy
52,700
+31,200
+145% +$2.66M 1.01% 24
2019
Q1
$1.95M Buy
+21,500
New +$1.83M 0.43% 54
2017
Q2
– Sell
-72,000
Closed -$4.99M – 182
2017
Q1
$4.99M Buy
+72,000
New +$4.84M 1.02% 34

Other funds holding XBI

Deltec Asset Management's XBI Position: Q3 2026 in Review

Deltec Asset Management reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 36% in Q3 2026, selling an estimated $789K and leaving 9,000 shares worth $1.42M. The position accounts for 0.22% of the portfolio, ranked #63.

Deltec Asset Management first reported a position in XBI in Q1 2017 and has held it in 20 quarters since. The position peaked at $4.99M in Q1 2017. 952 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Deltec Asset Management held 9,000 shares of State Street SPDR S&P Biotech ETF worth $1.42M as of Q3 2026.
  • Deltec Asset Management sold 5,000 State Street SPDR S&P Biotech ETF shares in Q3 2026, an estimated $789K.
  • State Street SPDR S&P Biotech ETF made up 0.22% of Deltec Asset Management's portfolio in Q3 2026, its #63 holding.
  • Deltec Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q1 2017 and has held it in 20 quarters since.
  • Deltec Asset Management's State Street SPDR S&P Biotech ETF position peaked at $4.99M in Q1 2017.
  • 952 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Deltec Asset Management's 13F filing for Q3 2026, filed 26 Oct 2026.